Skip to main content

Osteoporosis of the Spine

Bone-weakening disease that makes the spine vulnerable to compression fractures with minimal force

ICD-10: M81.0 · systemic condition

Osteoporosis is a condition in which bones lose density and strength, becoming brittle and susceptible to fracture. The spine is one of the most common sites affected — osteoporotic vertebral compression fractures (VCFs) are the most common fragility fracture, with an estimated 700,000 occurring in the United States annually. Spinal osteoporosis is most prevalent in postmenopausal women and older adults, but also affects men and younger individuals with certain risk factors. Many people are unaware they have osteoporosis until a fracture occurs.

Symptoms

  • Sudden, severe back pain that is new and localized to a specific vertebral level (compression fracture)
  • Gradual height loss of an inch or more over years
  • Increasing rounded posture or forward-bent spine (kyphosis)
  • Back pain that worsens with standing or walking and improves with lying down
  • Rib or hip pain from non-spine fractures in severe cases
  • In early stages: often no symptoms — osteoporosis is frequently discovered only after a fracture

Causes & Risk Factors

  • Postmenopausal estrogen decline — the most common cause in women
  • Advanced age — bone loss accelerates after age 50 in both sexes
  • Low calcium and vitamin D intake throughout life
  • Sedentary lifestyle — weight-bearing exercise is essential for bone maintenance
  • Long-term corticosteroid use (prednisone, dexamethasone) — a leading medication-induced cause
  • Family history of osteoporosis or fractures
  • Smoking and excessive alcohol consumption
  • Low body weight and poor nutritional status
  • Secondary causes: thyroid disease, hyperparathyroidism, malabsorption syndromes

Imaging Findings

Imaging studies are commonly used to identify findings associated with this condition. Results vary by individual; a qualified spine specialist interprets findings in the context of a full clinical evaluation.

MRI

  • MRI with STIR sequences can confirm acute osteoporotic vertebral fractures by showing bone marrow oedema; distinguishes acute from chronic fracture and helps identify the fracture level causing pain
  • Critical for excluding pathological fractures (malignancy, infection): paraspinal mass, diffuse marrow infiltration, and multiple atypical fractures prompt further workup
  • MRI cord/nerve root assessment is obtained when neurological complications of vertebral collapse or progressive kyphotic deformity are suspected; results vary by individual and require specialist interpretation

CT Scan

  • CT provides detailed bone architecture: trabecular density (Hounsfield units correlate with bone quality), fracture morphology, and posterior wall integrity for vertebroplasty/kyphoplasty planning
  • Low bone density on CT (HU <110 at L1 correlates with osteoporosis on DXA) can be identified opportunistically on CT obtained for other indications
  • CT with HU measurement of vertebral bodies is increasingly used for surgical planning to identify low-density bone requiring augmentation techniques

X-Ray

  • Standing lateral thoracic and lumbar radiographs allow Genant semi-quantitative assessment of vertebral fractures: anterior, middle, and posterior vertebral height measurements; >20% height loss defines fracture
  • Vertebral Fracture Assessment (VFA) on DXA scanner — a low-dose lateral spine image — is an efficient tool for identifying prevalent vertebral fractures in patients undergoing bone density testing
  • Generalised osteopenia (reduced bone density) may be visible on plain films but is not a reliable diagnostic tool — DXA is required for formal measurement

Who Is Commonly Affected

The following patterns are commonly associated with this condition based on published population studies. Individual presentation varies; these figures are informational only.

Peak Age Range

Osteoporosis-related vertebral fractures predominantly affect postmenopausal women (over 50) and men over 70; risk accelerates with each decade after menopause

Gender Distribution

Women are affected 2-3 times more often than men; postmenopausal oestrogen decline is the primary driver of the sex difference

Estimated Prevalence

Globally, osteoporosis affects approximately 200 million people; 1 in 3 women and 1 in 5 men over 50 will experience an osteoporotic fracture in their lifetime; vertebral fractures are the most common osteoporotic fracture, with approximately 1.4 million occurring annually worldwide; based on published population studies, individual presentation varies

Treatment Options

Conservative

  • Calcium supplementation (1,000–1,200 mg/day) and vitamin D (800–2,000 IU/day)
  • Bisphosphonates (alendronate, risedronate, zoledronic acid) — first-line medications that reduce fracture risk by 40–70%
  • Denosumab (Prolia) — injectable biologic for postmenopausal women at high risk
  • Teriparatide or abaloparatide — anabolic agents that stimulate new bone formation for severe osteoporosis
  • Romosozumab — newer biologic that both builds bone and reduces resorption
  • Fall prevention strategies: home safety assessment, balance training, appropriate footwear
  • Weight-bearing exercise and resistance training to maintain bone density
  • Physical therapy for posture correction and strengthening to reduce fracture risk

Surgical

  • Vertebroplasty — injection of bone cement into a fractured vertebra to stabilize it and reduce pain
  • Kyphoplasty — balloon is inflated to restore vertebral height before cement injection; may provide slightly better height restoration than vertebroplasty
  • Spinal fusion — for rare cases with severe instability or neurological compromise from multiple fractures

When to see a spine specialist

See a physician if you have sudden onset localized back pain — especially if you are over 50 or have risk factors for osteoporosis — as this may represent a compression fracture requiring prompt evaluation. All postmenopausal women and men over 70 should have a DEXA scan to assess bone density. If you have already had a fracture, see an endocrinologist, rheumatologist, or your primary care physician to initiate osteoporosis treatment and prevent future fractures.

Find a specialist who treats osteoporosis of the spine

NPI-verified spine surgeons in your city.

Search all cities →

Find a spine specialist near you

Browse NPI-listed spine surgeons and neurosurgeons who treat osteoporosis of the spine. Filter by location, insurance, and availability.

Search spine specialists →

Looking for a treatment facility?

Search hospitals, ASCs, and imaging centers by zip code.

Browse facilities →

Questions to Ask Your Doctor

Bring these questions to your next appointment about osteoporosis of the spine.

  1. 1

    Has my bone mineral density been formally measured with a DXA scan — and what do my T-score and FRAX 10-year fracture probability scores mean for my management?

  2. 2

    Are there secondary causes of osteoporosis in my case (steroid use, malabsorption, hypogonadism, hyperparathyroidism) that should be identified and treated before or alongside bone-specific medications?

  3. 3

    Which medication is recommended for my level of fracture risk — bisphosphonate, denosumab, romosozumab, or teriparatide — and how long should I expect to take it?

  4. 4

    What vertebral fractures, if any, have been identified on my imaging — and how do those affect my management and fracture risk going forward?

  5. 5

    What can I do to reduce my fall risk and protect my spine — including exercise, calcium and vitamin D supplementation, home safety, and medication review?

Frequently Asked Questions

How is osteoporosis of the spine diagnosed?

Osteoporosis is diagnosed with a DEXA (dual-energy X-ray absorptiometry) scan, which measures bone mineral density (BMD) at the spine and hip. A T-score of −2.5 or below at either site confirms osteoporosis. Blood tests evaluate calcium, vitamin D, thyroid function, and secondary causes. Spinal X-rays or MRI are used when a vertebral fracture is suspected.

How long should I take bisphosphonates?

Treatment duration depends on your fracture risk and the specific medication. Most guidelines recommend 3–5 years of oral bisphosphonates (e.g., alendronate), after which a "drug holiday" may be considered for lower-risk patients. Intravenous zoledronic acid is typically given for 3 years, with reassessment afterward. High-risk patients may continue longer. Do not stop without consulting your physician.

Can exercise prevent osteoporosis?

Yes — weight-bearing exercise (walking, hiking, dancing) and resistance training stimulate bone remodeling and help maintain bone density throughout life. Exercise is most effective when started before significant bone loss occurs. Balance training (tai chi, yoga) also reduces fall risk, which is critical for preventing fragility fractures.

What is the recovery from a vertebral compression fracture?

Most osteoporotic VCFs heal with conservative management in 6–12 weeks: rest, pain medications, bracing if needed, and avoiding heavy lifting. Kyphoplasty or vertebroplasty is considered when pain is severe and uncontrolled after 3–6 weeks of conservative care. After fracture, addressing the underlying osteoporosis is critical — the risk of subsequent fracture is dramatically elevated in the months following the first one.

Related Conditions

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. ICD-10: M81.0.